|Mr. Andre Calantzopoulos||Executive Chairman of the Board||N/A||N/A||1958|
|Mr. Jacek Olczak||CEO & Director||6.02M||N/A||1965|
|Mr. Emmanuel Babeau||Chief Financial Officer||3.54M||N/A||1967|
|Mr. Frederic de Wilde||President of South & Southeast Asia, Commonwealth of Ind. States and Middle East & Africa Region||2.28M||N/A||1967|
|Mr. Stefano Volpetti||President of Smoke-Free Inhalable Products & Chief Consumer Officer||2.31M||N/A||1972|
|Scott Coutts||Senior Vice President of Operations||N/A||N/A||N/A|
|Mr. Frank De Rooij||Vice President of Treasury & Corporate Finance||N/A||N/A||1966|
|Prof. Manuel C. Peitsch||Chief Science Officer||N/A||N/A||N/A|
|Mr. Michael Voegele||Chief Digital & Information Officer||N/A||N/A||1973|
|Mr. James R. Bushnell||Vice President of Investor Relations & Financial Communications||N/A||N/A||N/A|
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.
Philip Morris International Inc.’s ISS governance QualityScore as of 28 November 2023 is 6. The pillar scores are Audit: 8; Board: 9; Shareholder rights: 5; Compensation: 1.